Lansoprazol 1 A Pharma (Lansoprazole)

Lansoprazole works by irreversibly inhibiting the H+/K+ ATPase enzyme, also known as the gastric proton pump, on the secretory surface of parietal cells. This blockade stops the final step of acid secretion, leading to a sustained reduction in gastric acidity and an increase in stomach pH, which promotes healing of acid‑related lesions.

The appropriate dose of lansoprazole is determined by the prescribing clinician based on the specific indication, severity of disease, and patient characteristics. Dosage regimens may vary, and the prescriber will tailor the treatment plan to achieve optimal therapeutic effect while minimizing risk.

Safety data for lansoprazole during pregnancy and lactation are limited. It should only be used if the potential benefit justifies any possible risk to the fetus or infant. Healthcare providers should evaluate the individual situation and discuss alternatives before prescribing to pregnant or nursing women.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, and will request verification of trade or institutional credentials. After confirmation, the sales team provides pricing, availability, shipping details (including any cold‑chain requirements) and assists with import documentation.

Lansoprazole belongs to the proton pump inhibitor class, offering more potent and longer‑lasting acid suppression than H2‑receptor antagonists such as ranitidine. Compared with other PPIs like omeprazole, it has a similar efficacy profile but may differ in pharmacokinetic properties, such as onset of action and metabolism, which can influence individual patient response.

Store the product at ambient temperature, preferably below 25 °C, in a dry place away from direct sunlight. Keep the tablets in the original container to protect them from moisture and humidity. Do not refrigerate or freeze the product, as temperature extremes may affect its stability.

Lansoprazol 1 A Pharma is taken orally. The tablet should be swallowed whole with a glass of water, preferably before a meal, usually in the morning. It should not be chewed, crushed, or dissolved unless specifically instructed by a healthcare professional.

Serious adverse events, although rare, include Clostridioides difficile infection, acute interstitial nephritis, severe hypomagnesemia, and life‑threatening skin reactions such as Stevens‑Johnson syndrome or toxic epidermal necrolysis. Patients should seek immediate medical attention if they experience persistent diarrhea, unexplained fever, rash, or muscle cramps while on therapy.

Lansoprazole is contraindicated in individuals with known hypersensitivity to lansoprazole or any other proton pump inhibitor. Caution is advised for patients with severe liver disease, those taking medications that require an acidic environment for absorption, and patients with a history of osteoporosis when used long‑term. A healthcare provider should evaluate suitability before initiating therapy.